Each Party will cooperate reasonably in the preparation, filing, prosecution, and maintenance of the other Partys Patents, the Product-Specific Technology Patents and the Joint Patents.
Akcea will control and be responsible for Prosecuting and Maintaining (i) the Akcea Core Technology Patents, and (ii) Akcea Manufacturing and Analytical Patents, including any Jointly-Owned Program Patents in (i) or (ii).
Notwithstanding the foregoing, Isis will at all times have the sole right to institute, prosecute, and control any Proceeding under this Section 7.5.3 to the extent involving any Isis Core Technology Patents or Isis Manufacturing and Analytical Patents.
Notwithstanding the preceding sentence, Biogen Idec will retain final decision-making authority as to the listing of all applicable Patent Rights for the Product that are not Isis Core Technology Patents or Isis Manufacturing and Analytical Patents, regardless of which Party owns such Patent Rights.
Subject to the terms and conditions of this Agreement, OncoGenex hereby grants to Isis a non-exclusive, non-transferable, limited license or sublicense, as the case may be, under the OncoGenex Product-Specific Technology Patents, solely to perform Isis responsibilities in the Project Plan.